Since our previously published and current data show decreased expression of three of the core ATGs (ATG5, ATG7 and Beclin-1) in melanoma, we decided to study the impact of NRF1 and NFE2L2 on the expression of these ATGs. This evidence concerns the gene NRF1 and melanoma.